[Therapeutic strategies and tactics in parkinsonism].
The main medication is Madopar and Sinemet; various additives are able to reduce the Dopa dose in order to avoid various side effects. Additives: Deprenil (Jumex), Amantadin derivatives) Symmetrell, PK Merz, Hofkomant). Furthermore Dopamin agonists (Umprel, Dopergin). Delpral for dyskinesias. Driving antidepressive in the morning (Noveril, Dixeran, Tofranil). In the evening tranquillizing antidepressive like Tryptizol, Saroten, Sinequan, Ludiomil, Tolvon. Anticholinergica for Salivation, L-Tryptophan in hot environment.
D000547:Amantadine / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001545:Benserazide / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008090:Lisuride / Q000627:therapeutic use; D009048:Motor Skills / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy
D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D004338:Drug Combinations; C005177:benserazide, levodopa drug combination; C009265:carbidopa, levodopa drug combination; D012642:Selegiline; D007980:Levodopa; D001545:Benserazide; D000547:Amantadine; D008090:Lisuride; D002230:Carbidopa
Therapeutische Strategie und Taktik.